非小细胞肺癌的一线化疗：基于组织学类型是否存在更优方案？ - Suppr

Suppr

超能文献

First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?

作者信息

Einhorn Lawrence H

出版信息

J Clin Oncol. 2008 Jul 20;26(21):3485-6. doi: 10.1200/JCO.2008.17.2056. Epub 2008 May 27.

DOI:10.1200/JCO.2008.17.2056

PMID:18506022

Abstract

摘要

相似文献

First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?非小细胞肺癌的一线化疗：基于组织学类型是否存在更优方案？

J Clin Oncol. 2008 Jul 20;26(21):3485-6. doi: 10.1200/JCO.2008.17.2056. Epub 2008 May 27.

Histology-based treatment: a new scenario in the management of advanced nonsmall cell lung cancer.

Curr Opin Oncol. 2009 Mar;21(2):97-8. doi: 10.1097/CCO.0b013e328322ca04.

Pemetrexed for the treatment of non-small-cell lung cancer.培美曲塞用于治疗非小细胞肺癌。

Expert Rev Anticancer Ther. 2009 Sep;9(9):1195-209. doi: 10.1586/era.09.97.

If histology matters..

J Clin Oncol. 2010 Apr 10;28(11):1810-2. doi: 10.1200/JCO.2009.27.1247. Epub 2010 Mar 8.

The evolving role of histology in the treatment of non-small cell lung cancer.

Med Health R I. 2010 Oct;93(10):317-9.

[Second line chemotherapy in metastatic non-small cell lung cancer].

Rev Prat. 2009 Sep 20;59(7):952-3.

Clinical trials referral resource. Clinical trials in non-small-cell lung cancer.临床试验转诊资源。非小细胞肺癌的临床试验。

Oncology (Williston Park). 1999 Oct;13(10):1384, 1387-8.

Chemotherapy for advanced stage non-small cell lung cancer.晚期非小细胞肺癌的化疗

Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):210-6. doi: 10.1053/j.semtcvs.2008.09.002.

Non-small cell lung cancer: from targeted therapy to tailored therapy.非小细胞肺癌：从靶向治疗到个体化治疗。

Expert Opin Pharmacother. 2012 Sep;13(13):1817-9. doi: 10.1517/14656566.2012.707645. Epub 2012 Jul 18.

New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.非小细胞肺癌的新型靶向治疗：聚焦于表皮生长因子受体

J Natl Compr Canc Netw. 2003 Jan;1 Suppl 1:S78-86.

引用本文的文献

Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.利用综合生物信息学分析鉴定肺鳞状细胞癌中的关键基因并评估临床结局

Oncol Lett. 2019 Dec;18(6):5859-5870. doi: 10.3892/ol.2019.10933. Epub 2019 Sep 30.

Clinical And Imageological Features Of Lung Squamous Cell Carcinoma With Mutations.伴有突变的肺鳞状细胞癌的临床及影像学特征

Cancer Manag Res. 2019 Oct 21;11:9017-9024. doi: 10.2147/CMAR.S223021. eCollection 2019.

Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling.Scribble 的缺失通过 Nox2/ROS 和 Nrf2/PD-L1 信号通路赋予 NSCLC 化疗中的顺铂耐药性。

EBioMedicine. 2019 Sep;47:65-77. doi: 10.1016/j.ebiom.2019.08.057. Epub 2019 Sep 5.

Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.免疫组织化学在预测非小细胞肺癌未特指患者治疗结果中的有效性。

J Cancer Res Clin Oncol. 2019 Oct;145(10):2495-2506. doi: 10.1007/s00432-019-03012-z. Epub 2019 Sep 7.

The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.肺鳞状细胞癌独特的代谢表型定义了对糖酵解抑制的选择性脆弱性。

Nat Commun. 2017 May 26;8:15503. doi: 10.1038/ncomms15503.

Rethinking cancer: current challenges and opportunities in cancer research.重新思考癌症：癌症研究中的当前挑战与机遇

Dis Model Mech. 2017 Apr 1;10(4):349-352. doi: 10.1242/dmm.030007.

Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer.靶向复制蛋白A与DNA相互作用的化学抑制剂可提高铂类化疗药物对肺癌和卵巢癌的疗效。

Biochem Pharmacol. 2015 Jan 1;93(1):25-33. doi: 10.1016/j.bcp.2014.10.013. Epub 2014 Nov 4.

Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma.非小细胞肺癌手术标本与术前标本的组织学比较，以鉴别“鳞状”和“非鳞状”细胞癌。

Diagn Pathol. 2014 May 29;9:103. doi: 10.1186/1746-1596-9-103.

Choroid metastases revealing primary clear cell adenocarcinoma of the lung effectively treated with cisplatin and pemetrexed: a case report.脉络膜转移瘤揭示了经顺铂和培美曲塞有效治疗的原发性肺透明细胞腺癌：一例报告。

J Med Case Rep. 2013 Dec 11;7:267. doi: 10.1186/1752-1947-7-267.

Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.XPD 基因多态性可预测非小细胞肺癌铂类化疗的临床疗效：24 项研究的荟萃分析。

PLoS One. 2013 Nov 15;8(11):e79864. doi: 10.1371/journal.pone.0079864. eCollection 2013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验